Clinical use of immunoassays in assessing exposure to fungi and potential health effects related to fungal exposure

Annals of Allergy, Asthma and Immunology

Volumn 92, Issue 5, 2004, Pages

  Trout, Douglas B ^a   Seltzer, James M ^b   Page, Elena H ^a   Biagini, Raymond E ^a   Schmechel, Detlef ^a   Lewis, Daniel M ^a   Boudreau, A Yvonne ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b Rancho Santa Fe ^*

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN; ALLERGEN; FUNGUS ANTIBODY; FUNGUS ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; MYCOTOXIN; TRICHOTHECENE DERIVATIVE;

ALLERGIC RHINITIS; ASTHMA; CLINICAL PRACTICE; COCCIDIA; COCCIDIOSIS; COLONY FORMING UNIT; CRYPTOCOCCUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FUNGUS; FUNGUS GROWTH; HISTOPLASMA; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOASSAY; MYCOSIS; NONHUMAN; PNEUMONIA; PRICK TEST; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SEROLOGY; ANIMAL; ENVIRONMENTAL EXPOSURE; IMMUNOLOGY; MALE; MICROBIOLOGY; PRESCHOOL CHILD;

ANIMALS; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; CHILD, PRESCHOOL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MICROBIOLOGY; FUNGI; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOASSAY; MALE; MYCOSES;

EID: 19344365852     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1081-1206(10)61754-1     Document Type: Review

References (76)

1. Miller JD. Fungi as contaminants in indoor air. Annos Environ. 1992;26A:2163-2172.
2. Institute of Medicine. Clearing the Air: Asthma and Indoor Air Exposures. Washington, DC: National Academy Press; 2000: 158-175.
3. Centers for Disease Control and Prevention. State of the science on molds and human health. July 18, 2002. Available at: http:// www.cdc.gov/nceh/ airpollution/images/moldsci.pdf. Accessed September 4, 2003.
4. Burge HA. Fungi: toxic killers or unavoidable nuisances? Ann Allergy Asthma Immunol. 2001;87(Suppl):52-56.
5. Page EH, Trout DB. The role of Stachybotrys mycotoxins in building-related illness. AIHAJ. 2001;62:644-648.
6. Mann A. Mold in schools: a health alert. USA Weekend. August 18-20, 2000:6-8. Available at: http://www.usaweekend.com/ 00_issues/0000820/000820mold. html. Accessed September 24, 2003.
7. Mann A. When mold takes hold. USA Weekend. July 19-21, 2002:6-9. Available at: http://www.usaweekend.com/ 02_issues/020721/020721moldapt.html. Accessed September 24, 2003.
8. Burge HA, Otten JA. Fungi. In: Bioaerosols: Assessment and Control. Cincinnati, OH: American Conference of Governmental Industrial Hygienists; 1999:19.1-19.7.
9. Hamilton RG, Biagini RE, Krieg EF, The Multi-Center Latex Skin Testing Study Task Force. Diagnostic performance of Food and Drug Administration-cleared serologic assays for natural rubber latex-specific IgE antibody. J Allergy Clin Immunol. 1999;103:925-930.
10. Gutman S. The role of Food and Drug Administration regulation of in vitro diagnostic devices-applications to genetics testing. Clin Chem. 1999;45:746-749.
11. Medical devices: classification/reclassification; restricted devices; analyte specific reagents. Federal Register. 1997;62: 62243-62260.
12. Biagini RE, Krieg EF, Pinkerton LE, Hamilton RG. Receiver operating characteristics analyses of Food and Drug Administration-cleared serological assays for natural rubber latex-specific immunoglobulin E antibody. Clin Diagn Lab Immunol. 2001;8:1145-1149.
13. Quinn CP, Semenova VA, Elie CM, et al. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis [serial online]. 2002. Available at: http://www.cdc.gov/ncidod/EID/vol8nolO/02-0380. html. Accessed September 29, 2003.
14. National Committee for Clinical Laboratory Standards. Evaluation methods and analytical performance characteristics of immunological assays for human immunoglobulin E (IgE) antibodies of defined allergen specificities; approved guideline. 1997. Available at: http://www.nccls.org/free/ILA20-A.pdf. Accessed September 29, 2003.
15. Hawranek T. Cutaneous mycology. Chem Immunol. 2002;81: 129-166.
16. Dismukes WE. Introduction to the mycoses. In: Goldman L, Bennett JC, editors. Cecil Textbook of Medicine, 21st rev ed. Philadelphia, PA: WB Saunders Co; 2000:1858-1860.
17. Pfaller MA, McGinnis MR. The laboratory and clinical mycology. In: Anaissie EJ, McGinnis MR, Pfaller MA, editors. Clinical Mycology. New York, NY: Churchill Livingstone; 2003: 67-79.
18. Yeo SF, Wong B. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev. 2002;15:465-484.
19. Alexander BD. Diagnosis of fungal infection: new technologies for the mycology laboratory. Transplant Infect Dis. 2002; 4(Suppl):32-37.
20. Mendelson M. Fungal infections in the immunocompromised. Microbiol Today. 2001;28:10-12.
21. Wheat LJ. Serologic diagnosis of fungal disease. In: Sarosi GA, Davies SF, editors. Fungal Diseases of the Lung, 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2000:17-29.
22. Morrison CJ, Lindsley MD. Serological approaches to the diagnosis of invasive fungal infection. In: Calderone RA, Cihlar RL, editors. Fungal Pathogenesis: Principles and Clinical Applications. New York, NY: Marcel Dekker Inc; 2002:667-716.
23. Bennett JE. Diagnosis and treatment of fungal infections. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison's Principles of Internal Medicine, 15th ed. New York, NY: McGraw-Hill; 2001:1168.
24. Bush RK. Diagnostic tests in allergy. In: Slavin RG, Reisman RE, editors. Expert Guide to Allergy and Immunology. Philadelphia, PA: American College of Physicians; 1999:1-22.
25. Hamilton RG, Adkinson NF. Clinical laboratory assessment of IgE-dependent hypersensitivity. J Allergy Clin Immunol. 2003; 111:S687-S701.
26. Sampson HA. Food allergy. J Allergy Clin Immunol. 2003; 111: S540-S547.
27. Dykewicz MS. Rhinitis and sinusitis. J Allergy Clin Immunol. 2003;111:S520-S529.
28. Ownby DR, Magera B, Williams PB. A blinded, multi-center evaluation of two commercial in vitro tests for latex-specific antibodies. Ann Allergy Asthma Immunol. 2000;84:193-196.
29. American Academy of Allergy, Asthma, and Immunology. The Allergy Report: Volume I: Diagnostic Testing. Arlington Heights, IL: American Academy of Allergy, Asthma, and Immunology; 2000:31-40.
30. Arellano R, Bradley J, Sussman G. Prevalence of latex sensitization among hospital physicians occupationally exposed to latex gloves. Anesthesiology. 1992;77:905-908.
31. Sampson HA. Food allergy. JAMA. 1997;278:1888-1894.
32. Burge HA. Fungus allergens. Clin Rev Allergy. 1985;34: 131-133.
33. Horner WE, Lehrer SB. Why are there still problems with fungal allergen extracts? In: Johanning E, editor. Bioaerosols, Fungi, and Mycotoxins: Health Effects, Assessment, Prevention, and Control. Albany, NY: Eastern New York Occupational and Environmental Health Center; 1999:166-168.
34. Helm RM, Squillace DL, Aukrust L, et al. Production of an International Reference Standard Alternaria extract, I: testing of candidate extracts. Int Arch Allergy Appl Immunol. 1987;82: 178-189.
35. DeZubiria A, Horner WE, Lehrer SB. Evidence for cross-reactive allergens among basidiomycetes: immunoprint-inhibition studies. J Allergy Clin Immunol. 1990;86:26-33.
36. Breitenbach M, Simon-Nobbe B. The allergens of Cladosporium herbarum and Alternaria alternata. Chem Immunol. 2002; 81:48-72.
37. Helbling A, Brander KA, Horner WE, Lehrer SB. Allergy to basidiomycetes. Chem Immunol. 2002;81:28-47.
38. Weichel M, Flückiger S, Crameri R. Molecular characterization of mould allergens involved in respiratory complications. Recent Res Dev Respir Crit Care Med. 2002;2:29-45.
39. Schmechel D, Simpson JP, Lewis DM. The production and characterization of monoclonal antibodies to the fungus Aspergillus versicolor. In: Proceedings of the Ninth International Conference on Indoor Air Quality and Climate; Monterey, CA; June 30-July 5, 2002.
40. Halsey J. Performance of a Stachybotrys chartarum serology panel [abstract of presentation at Western Society of Allergy, Asthma, and Immunology annual meeting]. Allergy Asthma Proc. 2000;21:174-175.
41. Richerson HB, Bernstein IL, Fink JN, et al. Guidelines for the clinical evaluation of hypersensitivity pneumonitis. Report of the Subcommittee on Hypersensitivity Pneumonitis. J Allergy Clin Immunol. 1989;84:839-844.
42. Schuyler M, Cormier Y. The diagnosis of hypersensitivity pneumonitis. Chest. 1997;111:534-536.
43. Cormier Y, Lacasse Y. Keys to the diagnosis of hypersensitivity pneumonitis: the role of serum precipitins, lung biopsy, and high-resolution computed tomography. Clin Pulm Med. 1996; 3:72-77.
44. Bernstein DI. Clinical assessment and management of occupational asthma. In: Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI, editors. Asthma in the Workplace, 2nd ed. New York, NY: Marcel Dekker Inc; 1999:145.
45. McFadden ER Jr. Asthma. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison's Principles of Internal Medicine, 15th ed. New York, NY: McGraw-Hill; 2001:1460.
46. Lushniak BD, Reh CM, Bernstein DI, Gallagher JS. Indirect assessment of 4,4′-diphenylmethane diisocyanate (MDI) exposure by evaluation of specific humoral immune responses to MDI conjugated to human serum albumin. Am J Ind Med. 1998;33:471-477.
47. Yoshida K, Ando M, Sakata T, Araki S. Prevention of summer-type hypersensitivity pneumonitis: effect of elimination of Trichosporon cutaneum from the patient's homes. Arch Environ Health. 1989;44:317-322.
48. Yocum MW, Saltzman AR, Strong DM, Donaldson JC, Ward GW, Walsh FM, Cobb OM, Elliott RC. Extrinsic allergic alveolitis after Aspergillus fumigatus inhalation. Am J Med. 1976; 61:939-945.
49. McSharry C, Anderson K, Bourke SJ, Boyd G. Takes your breath away-the immunology of allergic alveolitis. Clin Exp Immunol. 2002;128:3-9.
50. Schatz M, Patterson R, Fink J. Immunopathogenesis of hypersensitivity pneumonitis. J Allergy Clin Immunol. 1977;60: 27-37.
51. Rose C. Hypersensitivity pneumonitis. In: Harber P, Schenker MB, Balmes JR, editors. Occupational and Environmental Respiratory Disease. St. Louis, MO: Mosby Year Book Inc; 1996: 201-211.
52. Gruchow HW, Hoffman RG, Marx JJ, Emanuel DA, Rimm AA. Precipitating antibodies to farmer's lung antigens in a Wisconsin farming population. Am Rev Respir Dis. 1981;124:411-415.
53. Banham SW, McSharry C, Lynch PP, Boyd G. Relationships between avian exposure, humoral immune response, and pigeon breeders' disease among Scottish pigeon fanciers. Thorax. 1986;41:274-278.
54. Lynch DA, Rose CS, Way D, King TE Jr. Hypersensitivity pneumonitis: sensitivity of high-resolution CT in a population-based study. AJR Am J Roentgenol. 1992;59:469-472.
55. Terho EO. Diagnostic criteria for farmer's lung disease. Am J Ind Med. 1986;10:329.
56. Walker CL, Grammer LC, Shaughnessy MA, Duffy M, Stoltzfus VD, Patterson R. Diphenylmethane diisocyanate hypersensitivity pneumonitis: a serological evaluation. J Occup Med. 1989;31:315-319.
57. Bisht V, Singh BP, Arora N, Gaur SN, Sridhara S. Antigenic and allergenic cross-reactivity of Epicoccum nigrum with other fungi. Ann Allergy Asthma Immunol. 2002;89:285-291.
58. Gupta R, Singh BP, Sridhara S, Gaur SN, Kumar R, Chaudhary VK, Arora N. Allergenic cross-reactivity of Curvularia lunata with other airborne fungal species. Allergy. 2002;57:636-640.
59. Lin WL, Chou H, Tam MF, Huang MH, Han SH, Shen HD. Production and characterization of monoclonal antibodies to serine proteinase allergens in Penicillium and Aspergillus species. Clin Exp Allergy. 2000;30:1653-1662.
60. Makkonen K, Viitala KI, Parkkila, Niemela O. Serum IgG and IgE antibodies against mold-derived antigens in patients with symptoms of hypersensitivity. Clin Chim Acta. 2001;305: 89-98.
61. Johanning E, Biagini R, Hull D, Morey P, Jarvis B, Landsbergis P. Health and immunology study following exposure to toxigenic fungi (Stachybotrys chartarum) in a water-damaged office environment. Int Arch Occup Environ Health. 1996;68: 207-218.
62. Hodgson MJ, Morey P, Leung W, et al. Building-associated pulmonary disease from exposure to Stachybotrys chartarum and Aspergillus versicolor. J Occup Environ Med. 1998;40: 241-249.
63. Malkin R, Martinez K, Marinkovich V, Wilcox T, Wall D, Biagini R. The relationship between symptoms and IgG and IgE antibodies in an office environment. Environ Res. 1998;76: 85-93.
64. Immonen J, Laitinen S, Taskinen T, Pekkanen J, Nevalainen A, Korppi M. Mould-specific immunoglobulin G antibodies in students from moisture- and mould-damaged schools: a 3-year follow-up study. Pediatr Allergy Immunol. 2002;13:125-128.
65. Taskinen TM, Laitinen S, Nevalainen A, et al. Immunoglobulin G antibodies to moulds in school children from moisture problems schools. Allergy. 2002;57:9-16.
66. Barnes C, Buckley S, Pacheco F, Portnoy J. IgE reactive proteins from Stachybotrys chartarum. Ann Allergy Asthma Immunol. 2002;89:29-33.
67. Vesper SJ, Magnuson ML, Dearborn DG, Yike I, Haugland RA. Initial characterization of the hemolysin Stachylysin from Stachybotrys chartarum. Infect Immun. 2001;69:912-916.
68. Panchal RG, Smart ML, Bowser DN, Williams DA, Petrou S. Pore-forming proteins and their application in biotechnology. Curr Pharm Biotechnol. 2002;3:99-115.
69. Van Emon JM, Reed AW, Yike I, Vesper SJ. ELISA measurement of Stachylysin in serum to quantify human exposures to the indoor mold Stachybotrys chartarum. J Occup Environ Med. 2003;45:582-591.
70. Kuhn DM, Ghannoum MA. Indoor mold, toxigenic fungi, and Stachybotrys chartarum: infectious disease perspective. Clin Microbiol Rev. 2003;16:144-172.
71. Fung F, Clark R, Williams S. Stachybotrys, a mycotoxin producing fungus of increasing toxicologic importance. Clin Toxicol. 1998;315:79-86.
72. Robbins CA, Swenson LJ, Nealley ML, Gots RE, Kelman BJ. Health effects of mycotoxins in indoor air: a critical review. Appl Occup Environ Hyg. 2000;15:773-784.
73. Sudakin DL. Stachybotrys chartarum: current knowledge of its role in disease. Medscape General Medicine. 2000. Available at: http://medscape.com/ Medscape/G.n01/mgm0229.suda/ mgm0229.suda.html. Accessed September 29, 2003.
74. Terr A. Stachybotrys: relevance to human health. Ann Allergy Asthma Immunol. 2001;87(Suppl):57-63.
75. Chapman JA, Terr AI, Jacobs RL, Charlesworth EN, Bardana EJ. Toxic mold: phantom risk vs science. Ann Allergy Asthma Immunol. 2003;91:222-232.
76. Trout D, Bernstein J, Martinez K, Biagini R, Wallingford K. Bioaerosol lung damage in a worker with repeated exposure to fungi in a water damaged building. Environ Health Perspect. 2001;109:641-644.